Amgen (AMGN) PT Raised to $272 at UBS
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $442.36 +4.02%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
UBS analyst Colin Bristow raised the price target on Amgen (NASDAQ: AMGN) to $272.00 (from $260.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Legence Corp (LGN) PT Raised to $130 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
